ANNALS of Neurology USF Health Professionals, Texas Neurological Society, Teva Pharmaceuticals, Lone Star Chapter NMSS, ICHE, Pfizer EMD Serono, SUNY, Stony Brook Foundation, UTMB, Medscape CME, University of Buffalo, Serono Symposia International Foundation, University of Utah; royalties, Millipore (Chemicon International) Corporation. References 1. Schumacher FA, Beeve GW, Kibler RF, et al. Problems of experi- mental trials of therapy in multiple sclerosis. Ann N Y Acad Sci 1965;122:552–568. 2. Poser CM, Paty, DW, Scheinberg LC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neu- rol 1983;1:227–231. 3. Paty DW, Oger JJ, Kastrukoff LF, et al. MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding and CT. Neurology 1988; 38:180–185. 4. Barkhof F, Filippi M, Miller DH, et al. Comparison of MR imaging criteria at first presentation to predict conversion to clinically defi- nite MS. Brain 1997;120:2059–2069. 5. Fazekas F, Offenbacher H, Fuchs S, et al. Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis. Neurology 1988;38:1822–1825. 6. Tintor e´ M, Rovira A, Martine´ z M, et al. Isolated demyelinating syn- dromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis. Am J Neuro- radiol 2000;21:702–706. 7. Thompson AJ, Montalban X, Barkhof F, et al. Diagnostic criteria for primary progressive multiple sclerosis: a position paper. Ann Neurol 2000;6:831–835. 8. 10. 300 McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121–127. 9. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the ‘‘McDonald Criteria.’’ Ann Neurol 2005;58:840–846. Dalton CM, Brex,PA, Miszkiel KA, et al. Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis. Ann Neurol 2002;52:47–53. 11. CHAMPS Study Group.MRI predictors of early conversion to clini- cally definite MS in the CHAMPS placebo group. Neurology 2002; 59:998–1005. 12. Barkhof F, Rocca M, Francis G, et al. Validation of diagnostic mag- netic resonance imaging criteria for multiple sclerosis and response to interferon beta-1a. Ann Neurol 2003;53:718–724. 13. Tintor e´ M, Rovira A, Rio J, et al. New diagnostic criteria for multi- ple sclerosis. Application in first demyelinating episode. Neurol- ogy 2003;60:27–30. 14. Charil A, Yousry TA, Rovaris M, et al. MRI and the diagnosis of multiple sclerosis: expanding the concept of ‘‘no better explana- tion.’’ Lancet Neurol 2006:10:841–852. 15. Miller DH, Weinshenker BG, Filippi M, et al. Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler 2008;14:1157–1174. 16. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoanti- body marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004:364:2106–2012. 17. Lennon VA, Kryzer TJ, Pittock SJ, et al. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005;202:473–477. 18. Shimizu J, Hatanaka Y, Hasegawa M, et al. IFNb-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spec- trum. Neurology 2010;75:1423–1427. 19. Wingerchuk DM, Lennon VA, Lucchinetti CF, et al. The spectrum of neuromyelitis optica. Lancet Neurol 2007:6:805–815. 20. Carroll WM, Fujihara K. Neuromyelitis optica. Curr Treat Options Neurol 2010;12:244–255. 21. Hawkes CH, Giovannoni G. The McDonald Criteria for multiple sclerosis: time for clarification. Mult Scler 2010;16:566–575. 22. Swanton JK, Rovira A, Tintor e´ M, et al. MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study. Lancet Neurol 2007;6:677–686. 23. Rovira A, Swanton J, Tintore´ M, et al. A single, early magnetic res- onance imaging study in the diagnosis of multiple sclerosis. Arch Neurol 2009;5:287–292. 24. 25. Montalban X, Tintor e´ M, Swanton J, et al. MRI criteria for MS in patients with clinically isolated syndromes. Neurology 2010;74: 427–434. McHugh JC, Galvin PL, Murphy RP. Retrospective comparison of the original and revised McDonald Criteria in a general neurology practice in Ireland. Mult Scler 2008;14:81–85. 26. Albertyn C, O’Dowd S, McHugh J, Murphy R. Compliance with McDonald criteria and red flag recognition in a general neurology practice in Ireland. Mult Scler 2010;16:678–684. 27. Swanton JKFernando K, Dalton CM, et al. Modification of MRI cri- teria for multiple sclerosis in patients with clinically isolated syn- dromes. J Neurol Neurosurg Psychiatry 2006;77:830–833. 28. Tur C, Tintor e´ M, Rovira A, et al. Very early scans for demonstrating dis- semination in time in multiple sclerosis. Mult Scler 2008;14:631–635. 29. Heun R, Kappos L, Bittkau S, et al. Magnetic resonance imaging and early diagnosis of MS. Lancet 1988;2:1202–1203. 30. Tas MW, Barkhof F, van Walderveen MA, et al. The effect of gad- olinium on the sensitivity and specificity of MR in the initial diag- nosis of multiple sclerosis. Am J Neuroradiol 1995;16:259–264. 31. Freedman MS, Thompson EJ, Deisenhammer F, et al. Recom- mended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement. Arch Neurol 2005;62: 865–870. 32. Masiuan J, Alvarez-Cermen˜ o JC, Garc´ıa-Barraga´ n N, et al. Clini- cally isolated syndromes: a new oligoclonal band test accurately predicts conversion to MS. Neurology 2006;66:576–578. 33. Tintor e´ M, Rovira A, Rı´o J, et al. Do oligoclonal bands add infor- mation to MRI in first attacks of multiple sclerosis? Neurology 2008;70:1079–1083. 34. Polman CH, Wolinsky JS, Reingold SC. Multiple sclerosis diagnos- tic criteria: three years later. Mult Scler 2005;11:5–12. 35. Hawker K, O’Connor P, Freedman MS, et al. Rituximab in patients with primary progressive multiple sclerosis: results of a random- ized double-blind placebo-controlled multicenter trial. Ann Neurol 2009;66:460–471. 36. Montalban X, Sastre-Garriga J, Filippi M, et al. Primary progres- sive multiple sclerosis diagnostic criteria: a reappraisal. Mult Scler 2009;15:1459–1465. 37. Absinta MA, Rocca MA, Moiola L, et al. Brain macro- and micro- scopic damage in patients with pediatric MS. J Neuro Neurosurg Psychiatry 2010;81:1357–1362. 38. Callen DJA, Shroff MM, Branson HM, et al. MRI in the diagnosis of pediatric multiple sclerosis. Neurology 2009;72:961–967. 39. Chong HT, Kira J, Tsai CP, et al. Proposed modifications to the McDonald criteria for use in Asia. Mult Scler 2009;15:887–888. 40. Chong HT, Li PCK, Singhal BJ, et al. Proposed modification to McDonald diagnostic criteria for Asians with multiple sclerosis. Neurol Asia 2006;11:87–90. Volume 69, No. 2